U.S. Software Stock News

NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Should Twist Bioscience’s US$17.05 Million Class Action Settlement Reshape Risk Perceptions for TWST Investors?

Twist Bioscience Corporation recently held a hearing on a proposed US$17,050,000 cash settlement to resolve a securities class action covering purchasers of its common stock between December 20, 2018 and November 15, 2022, as well as participants in its December 2020 offering. The proposed settlement, if fully approved, would close off ongoing litigation risk for a large group of past investors and clarify Twist Bioscience’s legal exposure tied to earlier capital-raising activities. We’ll...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore (EVR) After Strong Earnings And A New Dividend Still Looks Undervalued

Evercore (EVR) drew fresh attention on July 29, 2026 after reporting second quarter and first half earnings, alongside a new quarterly dividend declaration. This gave investors updated clues about profitability, revenue mix, and capital returns. See our latest analysis for Evercore. Evercore shares closed at US$320.56 on July 31, 2026, with the 1-day share price return of 2.46% coming after the latest earnings and dividend news. The 1-year total shareholder return of 10.17% sits against a...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Is Mercury Systems (MRCY) Undervalued Or Is Its Recovery Story Already Priced In?

Mercury Systems (MRCY) is in focus for investors after recent trading left the stock at a last close of US$97.10, with returns mixed over the past week, month, and past 3 months. See our latest analysis for Mercury Systems. The recent pullback, with a 30 day share price return down 21.09%, comes after stronger momentum earlier in the year. This includes a 23.62% 90 day share price return and a 1 year total shareholder return of 86.12%. If Mercury Systems has you looking beyond a single stock,...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

CRISPR Therapeutics (CRSP) Stock Looks Fairly Valued Despite Pipeline Promise

CRISPR Therapeutics has delivered a steep share price decline of about 64.9% over the past 5 years, yet on broad valuation checks the stock now looks closer to fairly valued than like a clear bargain or clear bubble. The roughly 64.9% slide over 5 years highlights how much long term shareholders have given up in returns, which naturally raises the bar for any new investment case. Progress on CRISPR Therapeutics' allogeneic CAR-T programs, including the Phase 1 work on CTX112 aimed at off the...
NasdaqGS:INNV
NasdaqGS:INNVHealthcare

InnovAge Holding (INNV) Faces A Valuation Test Following Its Shelf Registration

InnovAge Holding (INNV) has filed a shelf registration for up to US$1.31 billion of common stock, covering 112,988,070 shares. This filing gives the company scope to raise equity capital when conditions appear suitable. See our latest analysis for InnovAge Holding. The shelf registration arrives after a strong period for InnovAge Holding, with the share price up 36.54% over 90 days and a year to date share price return of 118.88%. The 1 year total shareholder return of 262.94% points to...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC) Looks Fairly Valued On Leadership Reshuffle and Supply Chain Changes

Henry Schein (HSIC) is reshaping its leadership structure after announcing the new Henry Schein Leadership Team to replace its Executive Management Committee and integrating its global supply chain group with its global distribution operations. See our latest analysis for Henry Schein. Over the past year, Henry Schein has seen building momentum, with a 90 day share price return of 15.99% and a 1 year total shareholder return of 26.14% at a share price of US$85.75. If leadership changes have...
NasdaqCM:UROY
NasdaqCM:UROYOil and Gas

Is Uranium Royalty (UROY) Rethinking Public-Market Exposure After Profit Jump and SEC Deregistration?

Uranium Royalty Corp. recently reported full-year 2026 results showing sales of US$186.81 million and net income of US$40.25 million, and later filed a Form 15 to voluntarily deregister its common shares with the SEC under the Exchange Act. Together with the withdrawal of its CAD$150 million shelf registration and an upcoming CFO change, these actions point to a meaningful shift in how the company manages capital access and regulatory obligations. Next, we will examine how the strong...
OTCPK:SFDL
OTCPK:SFDLBanks

Security Federal (SFDL) Stock Stalls As Margins Strengthen And Valuation Questions Grow

Security Federal’s stock has barely moved in recent months, with the latest price flat at US$41.67, yet the earnings picture now tells a more complicated story. The headline for this quarter is margin power. Over the last 12 months the bank turned in a 20.8% net profit margin, ahead of the prior year, and earnings for that period sat 28.9% above the five year average. For short term traders the lack of price reaction may look like apathy. For longer term investors it raises a sharper question...
NYSE:WAL
NYSE:WALBanks

Did Stronger Q2 Earnings and Dividends Just Shift Western Alliance Bancorporation's (WAL) Investment Narrative?

In late July 2026, Western Alliance Bancorporation’s board declared a quarterly US$0.42 common dividend and a US$106.25 per share Series A preferred dividend alongside second-quarter results showing higher net interest income and net income than a year earlier. The combination of rising quarterly earnings, lower net loan charge-offs compared with the prior quarter, and continued share repurchases underpins a picture of active capital management and shareholder returns at the bank. We’ll now...
NYSE:SYK
NYSE:SYKMedical Equipment

Stryker (SYK) Could Be 16% Below Fair Value On Its Latest Results

Stryker (SYK) has drawn fresh investor attention after reporting second quarter 2026 results, with sales of US$6.6b and net income of US$1.3b, alongside higher earnings per share from continuing operations. See our latest analysis for Stryker. The sharp 1 day share price decline of 6.42% to US$325.70 after Stryker’s earnings reflects investor focus on softer organic sales and ongoing supply disruptions, even though the 3 month share price return of 10.51% and 5 year total shareholder return...
NYSE:KKR
NYSE:KKRCapital Markets

Stronger Q2 Earnings and Kuwait Pipeline JV Could Be A Game Changer For KKR (KKR)

KKR & Co. Inc. recently reported Q2 2026 net income of US$700.48 million, raised six‑month net income to US$1.11 billion year on year, affirmed a quarterly dividend of US$0.195 per share for August 2026, and expanded its infrastructure footprint through a US$16.00 billion Kuwait crude pipeline joint venture. The combination of stronger earnings per share and a long-duration, volume-tariff infrastructure partnership in Kuwait highlights KKR’s emphasis on fee-based, cash-generating assets...
NYSE:ADC
NYSE:ADCRetail REITs

Can Agree Realty (ADC) Justify Its Valuation Following Raised Guidance And A Dividend Increase?

Agree Realty earnings snapshot and what changed Agree Realty (ADC) just reported its second quarter and first half 2026 results, along with record investment activity, updated guidance for investment volume and AFFO per share, and a higher monthly dividend. The company reported second quarter revenue of US$205.1 million and net income of US$54.65 million, with diluted earnings per share from continuing operations of US$0.44 compared with US$0.43 a year earlier. For the first six months of...
NYSE:BROS
NYSE:BROSHospitality

Is Dutch Bros (BROS) Getting Too Expensive For Its Growth?

Dutch Bros stock has delivered a strong 128.3% return over the past three years, yet the valuation checks currently lean expensive and suggest the recent share price near US$65.83 leaves less obvious room for error. Over the past three years, Dutch Bros has returned 128.3%, which puts extra focus on whether the current price still reflects a reasonable balance between growth expectations and risk. Expectations for continued store expansion and revenue growth can support a premium valuation...
NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

AI Infrastructure Stocks Facing Rising Energy Costs Investors Should Not Ignore

Fresh conflict in the Middle East, rising energy prices and renewed inflation worries are shaking confidence in the 2026 stock market rally. For investors watching AI infrastructure enablers, that combination of higher costs and volatility can either pressure margins or create openings. This article looks at how the latest news links back to AI infrastructure related stocks, and why some could still look relatively well positioned while others may face tougher headwinds. The focus is on three...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

CareDx (CDNA) Following Raised Guidance And Profit Swing, Does The Stock Look Fully Valued

CareDx (CDNA) has caught investor attention after reporting second quarter results that showed year over year improvements in revenue and profitability, alongside higher full year 2026 revenue guidance and an employee stock offering filing. See our latest analysis for CareDx. The earnings beat and higher 2026 revenue guidance appear to have been a key catalyst for CareDx, with a 1 day share price return of 14.72% and a 30 day share price return of 49.74%. That adds to a 1 year total...
NasdaqGS:RKLB
NasdaqGS:RKLBAerospace & Defense

Rocket Lab (RKLB) Lands 3 More iQPS Electron Missions Bringing Total Bookings To 18

Rocket Lab has signed a new multi-launch agreement with iQPS for three dedicated Electron missions. The missions will deploy QPS-SAR satellites, bringing iQPS’ total booked launches on Electron to 18. This is the third multi-launch booking Rocket Lab has secured from iQPS within the past year. Rocket Lab (NasdaqGS:RKLB) continues to deepen its role in the commercial satellite market as iQPS selects the company again for QPS-SAR deployments. With 18 launches now booked by the same customer,...
NYSE:ESI
NYSE:ESIChemicals

How Element Solutions’ (ESI) Q2 Profit Jump and Flat Buybacks Will Impact Investors

Element Solutions Inc reported its second-quarter 2026 results, with sales rising to US$977.9 million from US$625.2 million and net income increasing to US$77.3 million from US$47.4 million, while a previously authorized buyback program saw no repurchases in the latest quarter but has cumulatively retired 63,734,799 shares for US$817.8 million since 2018. An interesting twist is that while quarterly revenue and earnings grew compared with a year earlier, net income for the first half of 2026...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

Paylocity (PCTY) Stock May Trade At A Discount As Ignite AI Expands

Paylocity Holding stock has had a difficult run over the past five years, while current checks send mixed valuation signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a large gap to the current price and the market multiples implying the shares are not cheap. Paylocity Holding has declined 43.0% over five years, which raises the question of whether the current price reflects overly cautious expectations or ongoing concerns. New AI driven products such as Paylocity...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Why Neogen (NEOG) Is Up 28.1% After Issuing 2027 Guidance And Narrowing Annual Losses

Neogen Corporation has released its fourth-quarter and full-year results for the period ended May 31, 2026, reporting revenue of US$225.3 million for the quarter and US$870.4 million for the year, alongside much lower net losses than the prior year despite slightly softer sales. The company also issued new fiscal 2027 revenue guidance of US$880 million to US$885 million, signaling management’s current expectations for stabilizing top-line performance after a year of modest revenue...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Microchip Technology (MCHP) Fair Value Back In Focus As Recovery Narrative Builds

Microchip Technology (MCHP) has come back into focus after Chief Operating Officer Richard J. Simoncic resigned, effective August 17, 2026, to lead private firm Menlo Microsystems as its new Chief Executive Officer. See our latest analysis for Microchip Technology. The recent leadership change at Microchip Technology comes after a period where the stock has given up ground in the short term, with the 30 day share price return down 16.24% and the 90 day share price return down 20.93%. However,...
NasdaqGS:FCFS
NasdaqGS:FCFSConsumer Finance

FirstCash Holdings (FCFS) Looks Pricey As Earnings Growth And Buybacks Lift Interest

FirstCash Holdings (FCFS) has caught investor attention after reporting higher revenue and net income for the second quarter and first half of 2026, alongside completing a US$150 million share repurchase program. See our latest analysis for FirstCash Holdings. The recent share repurchase activity, leadership transition announcement and stronger earnings have come alongside a 30.1% year to date share price return for FirstCash Holdings. The 1 year total shareholder return of 57.2% and 5 year...
NYSE:EE
NYSE:EEOil and Gas

Does Excelerate Energy’s Bigger Dividend Reveal a Deeper Capital Allocation Shift for EE?

Excelerate Energy, Inc. previously announced that its Board of Directors approved a quarterly cash dividend of US$0.09 per Class A share for the quarter ended June 30, 2026, payable on September 3, 2026 to shareholders of record on August 19, 2026, representing an approximately 13% increase from the prior quarter. This higher dividend highlights the company’s willingness to return more cash to shareholders, a decision that may matter for income-focused investors assessing Excelerate’s...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

How Investors May Respond To Hut 8 (HUT) Securing US$19.6 Billion In Long-Term AI Lease Deals

Hut 8 Corp. recently announced it had commercialized the second phase of its Beacon Point AI data center campus in Texas via a second 15-year triple-net lease for 352 MW of IT capacity with the same high-investment-grade tenant, fully contracting the site’s 1,000 MW utility allocation. This expansion lifts Beacon Point’s total base-term contract value to US$19.60 billion and positions Hut 8’s AI data center portfolio at 949 MW of contracted capacity backed entirely by investment-grade...
NasdaqGS:OLED
NasdaqGS:OLEDSemiconductor

Is Universal Display (OLED) Below Fair Value After Lower Guidance?

Universal Display stock has fallen a long way, with the share price down about 59.5% over the past five years, yet some valuation checks now flag it as potentially inexpensive relative to its fundamentals. After the company recently signalled that this year’s revenue is likely to come in at the lower end of its earlier range, investors are weighing that weaker outlook against a stock that already carries a long multi year decline. The roughly 59.5% decline over five years suggests many...